Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amedeo Tirandi

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
European Heart Journal|August 28, 2024
Von Willebrand factor in inflammation and heart failure: beyond thromboembolic and bleeding riskStefano Ministrini, Amedeo Tirandi
Frontiers in Cardiovascular Medicine|September 12, 2022
Physical activity to reduce PCSK9 levelsAmedeo Tirandi, Fabrizio Montecucco, Luca Liberale
European Journal of Clinical Investigation|July 3, 2023
Heart and vessels 'on fire'Amedeo Tirandi, Fabrizio Montecucco, Luca Liberale
Internal and Emergency Medicine|June 2, 2023
Malnutrition predicts mortality in heart failure patientsAmedeo Tirandi, Fabrizio Montecucco, Luca Liberale
European Journal of Clinical Investigation|February 5, 2020
Apolipoprotein E genetic variants in Mediterranean diet: CORDIOPREV studyAmedeo Tirandi, Fabrizio Montecucco, Federico Carbone
Cardiovascular Research|September 25, 2025
Beyond triglycerides lowering: rethinking the role of eicosapentaenoic acid in lipoprotein biologyAmedeo Tirandi, Anina Künzli, Giovanni G Camici
European Journal of Clinical Investigation|October 29, 2021
The role of metabolic syndrome in sudden cardiac death risk: Recent evidence and future directionsAmedeo Tirandi, Federico Carbone, Fabrizio Montecucco, et al.
Internal and Emergency Medicine|January 31, 2024
Sepsis in elderly patients: the role of neutrophils in pathophysiology and therapyDavide Ramoni, Amedeo Tirandi, Fabrizio Montecucco, et al.
Internal and Emergency Medicine|June 15, 2022
Predicting mortality in hospitalized COVID-19 patientsAmedeo Tirandi, Davide Ramoni, Fabrizio Montecucco, et al.
Polish Archives of Internal Medicine|January 16, 2024
Role of glucagon-like peptide-1 receptor agonists in the treatment of obesity, cardiovascular disease, and cerebrovascular diseaseAmedeo Tirandi, Fabrizio Montecucco, Federico Carbone, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
European Heart Journal|August 28, 2024
Von Willebrand factor in inflammation and heart failure: beyond thromboembolic and bleeding riskStefano Ministrini, Amedeo Tirandi
Frontiers in Cardiovascular Medicine|September 12, 2022
Physical activity to reduce PCSK9 levelsAmedeo Tirandi, Fabrizio Montecucco, Luca Liberale
European Journal of Clinical Investigation|July 3, 2023
Heart and vessels 'on fire'Amedeo Tirandi, Fabrizio Montecucco, Luca Liberale
Internal and Emergency Medicine|June 2, 2023
Malnutrition predicts mortality in heart failure patientsAmedeo Tirandi, Fabrizio Montecucco, Luca Liberale
European Journal of Clinical Investigation|February 5, 2020
Apolipoprotein E genetic variants in Mediterranean diet: CORDIOPREV studyAmedeo Tirandi, Fabrizio Montecucco, Federico Carbone
Cardiovascular Research|September 25, 2025
Beyond triglycerides lowering: rethinking the role of eicosapentaenoic acid in lipoprotein biologyAmedeo Tirandi, Anina Künzli, Giovanni G Camici
European Journal of Clinical Investigation|October 29, 2021
The role of metabolic syndrome in sudden cardiac death risk: Recent evidence and future directionsAmedeo Tirandi, Federico Carbone, Fabrizio Montecucco, et al.
Internal and Emergency Medicine|January 31, 2024
Sepsis in elderly patients: the role of neutrophils in pathophysiology and therapyDavide Ramoni, Amedeo Tirandi, Fabrizio Montecucco, et al.
Internal and Emergency Medicine|June 15, 2022
Predicting mortality in hospitalized COVID-19 patientsAmedeo Tirandi, Davide Ramoni, Fabrizio Montecucco, et al.
Polish Archives of Internal Medicine|January 16, 2024
Role of glucagon-like peptide-1 receptor agonists in the treatment of obesity, cardiovascular disease, and cerebrovascular diseaseAmedeo Tirandi, Fabrizio Montecucco, Federico Carbone, et al.
Pageof 3